Clinic Directory — coming soon. Are you an Australian peptide clinic?Apply to be listed →
Independent · Australian · Education only — not medical adviceAboutEditorial standardsHow we review
HomeEncyclopediaLL-37

LL-37

Cathelicidin antimicrobial peptide

Research

What it is

A human-derived antimicrobial peptide of research interest.

What the evidence shows

An active antimicrobial-peptide research field, but not translated into an approved Australian product.

Safety & reported risks

Research-stage; no consumer safety profile and no quality assurance outside controlled settings.

Status in Australia

Research stage. Not approved as a medicine in Australia.

How it’s lawfully accessed

No consumer pathway. Exists in Australia within research contexts.

Related peptides

Thymosin Alpha-1Immune-modulating peptideCompounded use

Sources & further reading

This entry is general information about LL-37, not a recommendation to use it. We don’t provide dosing, protocols or sourcing. Speak to a registered practitioner.

Written by The Peptides.au editorial team
Editorial review Checked against current TGA, ARTG and AHPRA public guidance
Last updated 1 June 2026

This is general education, not medical advice. Peptides.au does not sell, supply, recommend or promote any product or clinic. Always speak with a registered Australian health practitioner before making any health decision.